Filters
reset allOther countries
Results: 1 to 12 of 12
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PreventionGenetics United States | 61 | 36 |
|
Hereditary Spastic Paraplegia Comprehensive Panel PreventionGenetics United States | 87 | 106 |
|
Pure Hereditary Spastic Paraplegia Panel PreventionGenetics United States | 31 | 36 |
|
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel PreventionGenetics United States | 48 | 40 |
|
Comprehensive Neuropathy Panel PreventionGenetics United States | 82 | 71 |
|
Ataxia with Oculomotor Apraxia Panel PreventionGenetics United States | 3 | 3 |
|
Distal Hereditary Motor Neuropathy Panel PreventionGenetics United States | 30 | 22 |
|
PreventionGenetics United States | 2 | 1 |
|
Ataxia, Comprehensive Evaluation Athena Diagnostics Inc United States | 44 | 42 |
|
Ataxia, Complete Recessive Evaluation Athena Diagnostics Inc United States | 21 | 18 |
|
GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases Spain | 43 | 37 |
|
Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 23 | 16 |
|
Results: 1 to 12 of 12
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.